Investor · CHICAGO, IL

Daniel M. Rosenbloom

Open Daniel in the network graph →

Filings

31

SEC Form D

Connections

163

co-filers

Capital

—

across filings

Active

Apr 2014

to Apr 2016

Most-connected co-filers (163)

Eric M. Siegal · CHICAGO, IL29 shared Denise A. Olsen · CHICAGO, IL14 shared Peter B. Finn · Boston, MA12 shared Norman S. Geller · CHICAGO, IL11 shared Barry A. Malkin · CHICAGO, IL11 shared Craig R. Caffarelli · CHICAGO, IL9 shared Justin Klee · Cambridge, MA9 shared Stephen D. Chubb · Cambridge, MA9 shared Joshua Cohen · Cambridge, MA9 shared David C. Barker · Louisville, CO7 shared Niles C. Utlaut · Louisville, CO7 shared George Milne · Cambridge, MA7 shared Christopher F. Linneman · Boston, MA7 shared Jonathan J. Desimone · Boston, MA7 shared Gary M. Freeman · CHICAGO, IL7 shared Mikhail Plam · Louisville, CO7 shared James F. Kellogg Iii · Boston, MA7 shared Corporate Director Gpe Viii Investments Manager Limited · Nicosia, G45 shared Nolan Chicoine · Calgary, Alberta, Canada5 shared Felix Von Coerper · Cambridge, MA5 shared Michael A. Elrad · Chicago, IL5 shared RD Legal Capital, LLC · Cresskill, NJ5 shared Walter Gilbert · Cambridge, MA5 shared Isaac Cheng · Cambridge, MA5 shared

Recent filings (31)

Amylyx Pharmaceuticals, Inc.Jul 2020 · 23 co-filers$30.0M Amylyx Pharmaceuticals, Inc.Jan 2020 · 23 co-filers$20.0M Amylyx Pharmaceuticals, Inc.Dec 2019 · 23 co-filers$15.0M Amylyx Pharmaceuticals, Inc.Dec 2019 · 23 co-filers$15.0M Amylyx Pharmaceuticals, Inc.Nov 2018 · 23 co-filers$13.0M Aura Biosciences, Inc.Nov 2017 · 28 co-filers$11.5M Amylyx Pharmaceuticals, Inc.Aug 2017 · 15 co-filers$2.3M Aura Biosciences, Inc.Sep 2016 · 30 co-filers$8.0M Amylyx Pharmaceuticals, Inc.Aug 2016 · 14 co-filers$5.0M Amylyx Pharmaceuticals, Inc.Aug 2016 · 14 co-filers$5.0M GEM REALTY FUND VI, L.P.Apr 2016 · 19 co-filers$1.0B GEM REALTY FUND VI-A, L.P.Apr 2016 · 19 co-filers$1.0B GEM REALTY EVERGREEN FUND, L.P.Nov 2015 · 19 co-filers Amylyx Pharmaceuticals, Inc.Nov 2015 · 14 co-filers$1.6M Amylyx Pharmaceuticals, Inc.Nov 2015 · 14 co-filers$1.6M Vigeo Therapeutics, Inc.Jun 2015 · 6 co-filers$10.0M Active Owners Fund IIApr 2015 · 4 co-filers SUMERU EQUITY PARTNERS FUND L.P.Apr 2015 · 15 co-filers$600.0M SEP STRATEGIC ADVISERS FUND L.P.Apr 2015 · 15 co-filers Aura Biosciences, Inc.Mar 2015 · 22 co-filers$34.5M GEM BVP CO-INV-A, L.P.Nov 2014 · 16 co-filers$20.0M GEM BVP CO-INV, L.P.Nov 2014 · 16 co-filers$20.0M Aura Biosciences, Inc.Aug 2014 · 9 co-filers$4.0M Active Owners Fund IIApr 2014 · 2 co-filers Aura Biosciences, Inc.Jan 2014 · 14 co-filers$1.3M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Daniel in the interactive graph →